IDEAYA Biosciences (IDYA) Misses Q4 EPS by 5c

IDEAYA Biosciences (NASDAQ: IDYA) reported Q4 EPS of ($0.52), $0.05 worse than the analyst estimate of ($0.47). Revenue for the quarter came in at $3.9 million versus the consensus estimate of $8.84 million.

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.

You May Also Be Interested In

• SpaceX: New Street Research sees 22% upside from proposed IPO price
• Transportadora de Gas del Sur SA (ADR) (TGS) PT Raised to $48 at BofA Securities
• RH (RH) Tops Q1 EPS by 12c